Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis

Gene Therapy volume 22, pages 968–976 (2015)Cite this article

Subjects

Abstract

Granulysin is a cytolytic molecule with perforin and granzymes that is expressed by activated human CTLs, NK and γδ T cells, and it has broad antimicrobial activity, including to drug-sensitive and drug-resistant Mycobacterium tuberculosis. We hypothesized that approaches facilitating the expression of granulysin in M. tuberculosis-infected host cells in the lung may provide a novel treatment strategy for pulmonary TB. In this study, a recombinant replication-deficient adenovirus serotype 5-based rAdhGLi was constructed that expressed human granulysin in the cytosol of the U937 and RAW264.7 macrophage-like cell lines as confirmed by western blotting and co-localization technology using indirect immunofluorescence staining. Ninety-six hours after both cell lines were infected with M. tuberculosis, acid-fast staining and enumeration demonstrated that rAdhGLi-treated cells had a lower colony-forming units (CFU) of intracellular bacteria than culture medium or AdNull controls. Granulysin was only expressed in the lung and not in other organs following inhalation of rAdhGLi. In particular, immunocompetent BALB/c mice or SCID mice intranasally infected with ~200 CFU of virulent M. tuberculosis H37Rv intranasally were treated with rAdhGLi, and they showed decreased bacterial loads in the lung when compared with phosphate-buffered saline or AdNull controls. Importantly, a clear dose-dependent rAdhGLi treatment efficacy was found in infected BALB/c mice, with the most significant reduction in lung bacteria obtained in BALB/c mice treated with 109 plaque-forming units of rAdhGLi without any pathological changes. Our study indicates that rAdhGLi may be used as a novel and efficient treatment strategy with the capability to directly kill intracellular M. tuberculosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. WHO. Global Tuberculosis Report. Geneva: Switzerland, 2014.

  2. LoBue P . Extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2009; 22: 167–173.

    Article  Google Scholar 

  3. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575–1580.

    Article  Google Scholar 

  4. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282: 121–125.

    Article  CAS  Google Scholar 

  5. Gansert JL, Kiessler V, Engele M, Wittke F, Rollinghoff M, Krensky AM et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003; 170: 3154–3161.

    Article  CAS  Google Scholar 

  6. Farouk SE, Mincheva-Nilsson L, Krensky AM, Dieli F, Troye-Blomberg M . Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol 2004; 34: 2248–2256.

    Article  CAS  Google Scholar 

  7. Walch M, Dotiwala F, Mulik S, Thiery J, Kirchhausen T, Clayberger C et al. Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell 2014; 157: 1309–1323.

    Article  CAS  Google Scholar 

  8. Toro JC, Hoffner S, Linde C, Andersson M, Andersson J, Grundstrom S . Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype. Microbes Infect 2006; 8: 1985–1993.

    Article  CAS  Google Scholar 

  9. Okada M, Kita Y . Tuberculosis vaccine development: The development of novel (preclinical) DNA vaccine. Hum Vaccin 2010; 6: 297–308.

    Article  CAS  Google Scholar 

  10. Guo Y, Luan G, Shen G, Wu L, Jia H, Zhong Y et al. Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris. Appl Microbiol Biotechnol 2013; 97: 7669–7677.

    Article  CAS  Google Scholar 

  11. Walch M, Eppler E, Dumrese C, Barman H, Groscurth P, Ziegler U . Uptake of granulysin via lipid rafts leads to lysis of intracellular Listeria innocua. J Immunol 2005; 174: 4220–4227.

    Article  CAS  Google Scholar 

  12. Santosuosso M, McCormick S, Xing Z . Adenoviral vectors for mucosal vaccination against infectious diseases. Viral Immunol 2005; 18: 283–291.

    Article  CAS  Google Scholar 

  13. Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, Xing Z . Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 2005; 174: 7986–7994.

    Article  CAS  Google Scholar 

  14. Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 2007; 75: 4105–4115.

    Article  CAS  Google Scholar 

  15. Yao XL, Nakagawa S, Gao JQ . Current targeting strategies for adenovirus vectors in cancer gene therapy. Curr Cancer Drug Targets 2011; 11: 810–825.

    Article  CAS  Google Scholar 

  16. Liu B, Liu S, Qu X, Liu J . Construction of a eukaryotic expression system for granulysin and its protective effect in mice infected with Mycobacterium tuberculosis. J Med Microbiol 2006; 55: 1389–1393.

    Article  CAS  Google Scholar 

  17. Yi Z, Fu Y, Yang C, Li J, Luo X, Chen Q et al. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice. Vaccine 2007; 25: 638–648.

    Article  CAS  Google Scholar 

  18. Tewary P, Yang D, de la Rosa G, Li Y, Finn MW, Krensky AM et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010; 116: 3465–3474.

    Article  CAS  Google Scholar 

  19. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM . Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005; 174: 5243–5248.

    Article  CAS  Google Scholar 

  20. Ginsberg AM, Spigelman M . Challenges in tuberculosis drug research and development. Nat Med 2007; 13: 290–294.

    Article  CAS  Google Scholar 

  21. Zhang Y . Advances in the treatment of tuberculosis. Clin Pharmacol Ther 2007; 82: 595–600.

    Article  CAS  Google Scholar 

  22. Sacchettini JC, Rubin EJ, Freundlich JS . Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol 2008; 6: 41–52.

    Article  CAS  Google Scholar 

  23. Gonzalez-Juarrero M . Immunity to TB and targets for immunotherapy. Immunotherapy 2012; 4: 187–199.

    Article  CAS  Google Scholar 

  24. Wang CC, Zhu B, Fan X, Gicquel B, Zhang Y . Systems approach to tuberculosis vaccine development. Respirology 2013; 18: 412–420.

    Article  Google Scholar 

  25. Mata-Espinosa DA, Mendoza-Rodriguez V, Aguilar-Leon D, Rosales R, Lopez-Casillas F, Hernandez-Pando R . Therapeutic effect of recombinant adenovirus encoding interferon-gamma in a murine model of progressive pulmonary tuberculosis. Mol Ther 2008; 16: 1065–1072.

    Article  CAS  Google Scholar 

  26. Francisco-Cruz A, Mata-Espinosa D, Estrada-Parra S, Xing Z, Hernandez-Pando R . Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis. Clin Exp Immunol 2013; 171: 283–297.

    Article  CAS  Google Scholar 

  27. Romano M, Huygen K . DNA vaccines against mycobacterial diseases. Expert Rev Vaccines 2009; 8: 1237–1250.

    Article  CAS  Google Scholar 

  28. Harth G, Horwitz MA, Tabatadze D, Zamecnik PC . Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. Proc Natl Acad Sci USA 2002; 99: 15614–15619.

    Article  CAS  Google Scholar 

  29. Rosas-Taraco AG, Higgins DM, Sanchez-Campillo J, Lee EJ, Orme IM, Gonzalez-Juarrero M . Local pulmonary immunotherapy with siRNA targeting TGFbeta1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. Tuberculosis (Edinb) 2011; 91: 98–106.

    Article  CAS  Google Scholar 

  30. Cooper AM . Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27: 393–422.

    Article  CAS  Google Scholar 

  31. Stegelmann F, Bastian M, Swoboda K, Bhat R, Kiessler V, Krensky AM et al. Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J Immunol 2005; 175: 7474–7483.

    Article  CAS  Google Scholar 

  32. Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, Cho S et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001; 7: 174–179.

    Article  CAS  Google Scholar 

  33. Klucar P, Barnes PF, Kong Y, Samten B, Tvinnereim A, Spallek R et al. Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen. Hum Immunol 2008; 69: 475–483.

    Article  CAS  Google Scholar 

  34. Andersson J, Samarina A, Fink J, Rahman S, Grundstrom S . Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 2007; 75: 5210–5222.

    Article  CAS  Google Scholar 

  35. Di Liberto D, Buccheri S, Caccamo N, Meraviglia S, Romano A, Di Carlo P et al. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb) 2007; 87: 322–328.

    Article  CAS  Google Scholar 

  36. Sekiya M, Ohwada A, Katae M, Dambara T, Nagaoka I, Fukuchi Y . Adenovirus vector-mediated transfer of 9 kDa granulysin induces DNA fragmentation in HuD antigen-expressing small cell lung cancer murine model cells. Respirology 2002; 7: 29–35.

    Article  Google Scholar 

  37. Houben D, Demangel C, van Ingen J, Perez J, Baldeon L, Abdallah AM et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012; 14: 1287–1298.

    Article  CAS  Google Scholar 

  38. van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129: 1287–1298.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Mega-Projects of Science Research for the 12th Five-Year Plan (no. 2012ZX10003008-005), the Natural Science Foundation of China (no. 30671861) and Wuhan Bureau of Science and Technology (no. 2015060101010029).

Author information

Authors and Affiliations

  1. Department of Pathogen Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, China

    J Ma, J Lu, H Huang, X Teng, M Tian, Q Yu, X Yuan, Y Jing, C Shi, J Li & X Fan

Authors
  1. J Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Q Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. X Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. X Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X Fan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, J., Lu, J., Huang, H. et al. Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis. Gene Ther 22, 968–976 (2015). https://doi.org/10.1038/gt.2015.73

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2015.73

This article is cited by

Search

Advanced search

Quick links